Biologics Spine BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byChris StewartJune 22, 2022
Biologics InVivo Therapeutics Announces INSPIRE’S 29th Clinical Site: Rhode Island Hospital byJosh SandbergJanuary 11, 2017
Biologics InVivo Therapeutics Announces Ben Taub Hospital/Baylor College of Medicine as New Site for INSPIRE Study byJosh SandbergJuly 18, 2016
Biologics Pioneering global regenerative medical technology company, Tissue Regenix Group plc, officially opens new Leeds site byJosh SandbergMay 16, 2016
Spine Nuvasive Announces Location For New State-Of-The-Art Manufacturing Facility byJosh SandbergDecember 11, 2015
